my account  log out
 

Product Name:Celecoxib

Create: 04/17/2018
Expired Date:never
Category: Methacrylate intermediates [Chemical]
Message:Product Name:Celecoxib Another Name:CELEBREX; 4-[[5-(4-METHYLPHENYL)-3-TRIFLUOROMETHYL]-1H-PYRAZOL-YL]BENZENESULFONAMIDE; 4-[5-((4-METHYLPHENYL)-3-TRIFLUORPMETHYL)-1H-PYRAZOL-YL]BENENESULFONAMIDE; Celecoxib, 4-[5-(4-Methylphenyl)-3-trifluoromethyl)-1H-pyrazol-yl]benzenesulfonamide; Benzenesulfonamide, 4-5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl-; 4-[5-(4-methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide; Celebra- CAS: Molecular Weight:381.37 Molecular Formula:C17H14F3N3O2S [main adjuvant therapy use] treatment of osteoarthritis, rheumatoid arthritis and familial adenomatous polyposis Another Name:CELEBREX; 4-[[5-(4-METHYLPHENYL)-3-TRIFLUOROMETHYL]-1H-PYRAZOL-YL]BENZENESULFONAMIDE; 4-[5-((4-METHYLPHENYL)-3-TRIFLUORPMETHYL)-1H-PYRAZOL-YL]BENENESULFONAMIDE; Celecoxib, 4-[5-(4-Methylphenyl)-3-trifluoromethyl)-1H-pyrazol-yl]benzenesulfonamide; Benzenesulfonamide, 4-5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl-; 4-[5-(4-methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide; Celebra- CAS: Molecular Weight:381.37 Molecular Formula:C17H14F3N3O2S [main adjuvant therapy use] treatment of osteoarthritis, rheumatoid arthritis and familial adenomatous polyposis
City:Wuhan Hubei[CN] 
Location:
 
Jun 19 2018 Flunixin meglumin6666650
Jun 19 2018 Flunixin meglumin222251
Jun 19 2018 Flunixin meglumin555322347
Jun 19 2018 Flunixin meglumin56565249
Jun 19 2018 Flunixin meglumin53555248
Jun 19 2018 Flunixin meglumin56562351
Jun 19 2018 Flunixin meglumin5222247
Jun 19 2018 Flunixin meglumin525250
Jun 19 2018 Flunixin meglumin457456450
Jun 19 2018 Flunixin meglumin56+5656549

return back

Copyright © 2012-2017 toextrade Inc. All rights reserved. Contact us   DeepData©